40 likes | 149 Views
Explore bridging strategies in global drug development, highlighting factors influencing success and the importance of PK/PD analysis in diverse populations. Learn about future collaborative registration trials in Asia.
E N D
Advanced and Global Drug Development Techniques: Brigding Strategies and Pharmacogenomics Simltaneous/ Worldwide Development Strategies: Overview Thomas Kuerner, M.D. Nippon Boehringer Ingelheim Co., Ltd.
Key success factor for bridging • Clarify influence of extrinsic and intrinsic factors • Careful analysis of PK/PD in different populations • Confirmation of dose-response relationship in different ethnic groups • Confirmation of safety profile in submitted region The 3rd Kitasato-Harvard Symposium
Example from Asian Trials in mild to moderate essential hypertension using ARB The 3rd Kitasato-Harvard Symposium
Conclusions Past • Little experiences among regulatory agencies with Asian multi-center trials • Mostly retrospective bridging strategies applied by the sponsors Future • Prospective Asian collaborative registration trials • Ensuring of compliance to ICH agreed standards • Competitive enrollment will enhance performance in different Asian countries The 3rd Kitasato-Harvard Symposium